Sodium (2S,5R,6R)-3,3-Dimethyl-7-Oxo-6-[[2-[3-(Trifluoromethyl)Phenoxy]Acetyl]Amino]-4-Thia-1-Azabicyclo[3.2.0]Heptane-2-Carboxylate

CAS : 146554-88-3

Ref. 3D-FS103684

Informations sur le produit

• Nom: Sodium (2S,5R,6R)-3,3-Dimethyl-7-Oxo-6-[[2-[3-(Trifluoromethyl)Phenoxy]Acetyl]Amino]-4-Thia-1-Azabicyclo[3.2.0]Heptane-2-Carboxylate
• Synonymes: Ly 242072, Trifluoromethylpenicillin V, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(((3-(trifluoromethyl)phenoxy)acetyl)amino)-, monosodium salt, (2S-(2alpha,5alpha,6beta))-, sodium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-({[3-(trifluoromethyl)phenoxy]acetyl}amino)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

Description

(2S,5R,6R)-3,3-Dimethyl-7-Oxo-6-[(2-[3-(trifluoromethyl)phenoxy]acetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid is an antibiotic that inhibits the growth of bacteria by binding to bacterial ribosomes and preventing protein synthesis. It was first isolated from a strain of Streptomyces sp. collected in Taiwan in 1965 and has been shown to have activity against Gram positive and Gram negative bacteria as well as some protozoa. The drug is excreted in urine and can be detected using magnetic resonance imaging (MRI). This drug has also been used successfully to treat urinary tract infections in animals without inducing side effects on bladder tissue.

The 6-Fluoro-3indoxyl beta D galactopyranoside is

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 440.37 g/mol
• Formule: C₁₇H₁₆F₃N₂NaO₅S
• Degré de pureté: Min. 95%